Cite
HARVARD Citation
Moinard-Butot, F. et al. (2022). Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast. pp. 54-60. [Online].